- Home
- KG vs APLS Comparison
KG vs APLS Comparison
Compare KG & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- APLS
- Stock Information
- Founded
- KG N/A
- APLS 2009
- Country
- KG Bermuda
- APLS United States
- Employees
- KG N/A
- APLS N/A
- Industry
- KG Property-Casualty Insurers
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- KG Finance
- APLS Health Care
- Exchange
- KG Nasdaq
- APLS Nasdaq
- Market Cap
- KG 2.5B
- APLS 2.2B
- IPO Year
- KG N/A
- APLS 2017
- Fundamental
- Price
- KG N/A
- APLS $19.06
- Analyst Decision
- KG
- APLS Buy
- Analyst Count
- KG 0
- APLS 19
- Target Price
- KG N/A
- APLS $37.67
- AVG Volume (30 Days)
- KG 33.9K
- APLS 3.1M
- Earning Date
- KG 01-01-0001
- APLS 07-31-2025
- Dividend Yield
- KG N/A
- APLS N/A
- EPS Growth
- KG N/A
- APLS N/A
- EPS
- KG N/A
- APLS N/A
- Revenue
- KG N/A
- APLS $775,839,000.00
- Revenue This Year
- KG N/A
- APLS $1.54
- Revenue Next Year
- KG N/A
- APLS $22.80
- P/E Ratio
- KG N/A
- APLS N/A
- Revenue Growth
- KG N/A
- APLS 48.04
- 52 Week Low
- KG $21.81
- APLS $16.10
- 52 Week High
- KG $36.80
- APLS $43.76
- Technical
- Relative Strength Index (RSI)
- KG N/A
- APLS 55.19
- Support Level
- KG N/A
- APLS $16.61
- Resistance Level
- KG N/A
- APLS $19.73
- Average True Range (ATR)
- KG 0.00
- APLS 0.98
- MACD
- KG 0.00
- APLS 0.32
- Stochastic Oscillator
- KG 0.00
- APLS 81.40
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.